(IN BRIEF) The Fraunhofer-Gesellschaft has partnered with the Spanish government, Government of Catalonia, and city of Barcelona to establish a joint framework for advancing theranostics research in Spain — a field that combines diagnostics and therapy for personalized medicine. The … Read the full press release
Posted in Business, Germany, Government, News, Pharma & Biotech, Science, Spain, Technology
Tagged bioengineering, biomedical engineering, biotechnology, Catalonia, City of Barcelona, diagnostics, Diana Morant, Europe, Fraunhofer and Catalan Partners Establish Framework for Applied Theranostics Innovation, Fraunhofer and Spanish Partners Unite to Advance Theranostics and Personalized Medicine in Barcelona, Fraunhofer CAT, Fraunhofer Center for Applied Theranostics, Fraunhofer IBMT, Fraunhofer Spain Research Foundation, Fraunhofer-Gesellschaft, Government of Catalonia, Healthcare Innovation, Heiko Zimmermann, Holger Hanselka, IBEC, Jaume Collboni, Josep Samitier, life sciences, New Fraunhofer Initiative in Spain to Drive European Leadership in Theranostics Research, Núria Montserrat Pulido, personalized medicine, Peter Hauptmann, precision medicine, research collaboration, Salvador Illa, Spain and Germany Strengthen Research Ties Through New Fraunhofer Center for Theranostics in Barcelona, Spanish government, theranostics, therapy
(IN BRIEF) Eckert & Ziegler Radiopharma GmbH has entered into a clinical manufacturing agreement with Pentixapharm AG to supply GMP-grade Y90-PentixaTher doses for use in ongoing trials. The radiolabeled therapy targets cancers overexpressing the CXCR4 receptor and supports a theranostic … Read the full press release
Posted in Business, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged Acute myeloid leukemia, cancer treatment, clinical trials, CXCR4, Dirk Pleimes, Eckert & Ziegler, EZR, Ga68-PentixaFor, GMP manufacturing, Harald Hasselmann, lymphoma, Myeloma, nuclear medicine, Pentixapharm, radiopharmaceuticals, radiotherapy, solid tumors, targeted therapy, theranostics, Y90-PentixaTher
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?